Apricus Biosciences' partner in the United Kingdom accepts first shipment of Vitaros(R)
Apricus announced Takeda Pharmaceuticals, the Company's partner in the UK, has accepted the first shipment of Vitaros®, Apricus' novel topical on-demand treatment for erectile dysfunction. In Sept. 2012, Apricus and Takeda entered into an exclusive license agreement to market Vitaros® in the UK. April 16, 2014